Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 22227526)

1.

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission: have the indications changed?

Paun O, Lazarus HM.

Curr Opin Hematol. 2012 Mar;19(2):95-101. doi: 10.1097/MOH.0b013e32834ff54b. Review.

PMID:
22227526
2.

Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT.

Sengsayadeth S, Savani BN, Blaise D, Malard F, Nagler A, Mohty M.

Haematologica. 2015 Jul;100(7):859-69. doi: 10.3324/haematol.2015.123331. Review.

3.

Optimizing Quality and Efficiency of Healthcare Delivery in Hematopoietic Cell Transplantation.

Majhail NS.

Curr Hematol Malig Rep. 2015 May 24. [Epub ahead of print]

PMID:
26003329
4.

Is it time for erythropoietin use in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients?

Helbig G, Kyrcz-KrzemieĊ„ S.

Chin Clin Oncol. 2012 Dec;1(2):22. doi: 10.3978/j.issn.2304-3865.2012.11.13. No abstract available.

5.

Hematopoietic cell transplantation for acute leukemia: selecting donors.

Eapen M.

Haematologica. 2015 Apr;100(4):414-5. doi: 10.3324/haematol.2015.124974. No abstract available.

6.

Is it time to change conventional consolidation chemotherapy for acute myeloid leukemia in CR1?

Wolach O, Stone RM.

Curr Opin Hematol. 2015 Mar;22(2):123-31. doi: 10.1097/MOH.0000000000000119.

PMID:
25594168
7.

Approach to patients with primary refractory acute myeloid leukemia.

Orlowski RJ, Mangan JK, Luger SM.

Curr Opin Hematol. 2015 Mar;22(2):97-107. doi: 10.1097/MOH.0000000000000115.

PMID:
25575037
8.

Transplantation in acute myeloid leukemia.

Zuckerman T, Rowe JM.

Hematol Oncol Clin North Am. 2014 Dec;28(6):983-94. doi: 10.1016/j.hoc.2014.08.016. Epub 2014 Sep 30.

PMID:
25459174
9.

Genetic stratification in myeloid diseases: from risk assessment to clinical decision support tool.

Ofran Y.

Rambam Maimonides Med J. 2014 Oct 29;5(4):e0025. doi: 10.5041/RMMJ.10159. eCollection 2014 Oct.

10.

Advances in treating acute myeloid leukemia.

Showel MM, Levis M.

F1000Prime Rep. 2014 Oct 1;6:96. doi: 10.12703/P6-96. eCollection 2014. Review.

11.

Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.

Ikegawa S, Doki N, Yamamoto K, Shingai N, Takahashi Y, Aoki J, Yoshioka K, Narukawa K, Ishida S, Igarashi A, Oshikawa G, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K.

Leuk Lymphoma. 2015 Jun;56(6):1874-7. doi: 10.3109/10428194.2014.974044. Epub 2014 Nov 14. No abstract available.

PMID:
25311493
12.

[Current indications of allogeneic stem cell transplant in adults with acute myeloid leukemia].

Thomas X.

Bull Cancer. 2014 Sep;101(9):856-65. doi: 10.1684/bdc.2014.1944. Review. French.

PMID:
25296413
13.

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective.

Yanada M.

Int J Hematol. 2015 Mar;101(3):243-54. doi: 10.1007/s12185-014-1657-0. Epub 2014 Sep 12.

PMID:
25212675
14.

Optimal benefits for hematopoietic stem cell transplantation: a consensus opinion.

Maziarz RT, Farnia S, Martin P, Komanduri KV.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1671-6. doi: 10.1016/j.bbmt.2014.07.007. Epub 2014 Jul 12.

PMID:
25020102
15.

Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy.

Medeot M, Tiribelli M, Patriarca F, Sperotto A, Geromin A, Fanin R.

Am J Hematol. 2014 Sep;89(9):933-4. doi: 10.1002/ajh.23769. Epub 2014 Jun 19. No abstract available.

PMID:
24861480
16.

Indications for allogeneic hematopoietic cell transplantation for acute myeloid leukemia in the genomic era.

Appelbaum FR.

Am Soc Clin Oncol Educ Book. 2014:e327-33. doi: 10.14694/EdBook_AM.2014.34.e327.

17.

Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of age.

Michaelis LC, Hamadani M, Hari PN.

Expert Rev Hematol. 2014 Jun;7(3):321-4. doi: 10.1586/17474086.2014.913978. Epub 2014 May 2.

PMID:
24785114
18.

Leukemia stem cell candidates in acute myeloid leukemia predict refractoriness to conventional chemotherapy and adverse clinical outcome.

Ran D, Taubert I, Schubert M, Eckstein V, Bellos F, Ho AD.

J Stem Cells Regen Med. 2010 Oct 23;6(2):135-6. eCollection 2010. No abstract available.

PMID:
24693144
19.

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: are we closer to knowing who needs it?

Lekakis LJ, Cooper BW, de Lima MG.

Curr Hematol Malig Rep. 2014 Jun;9(2):128-37. doi: 10.1007/s11899-014-0207-4. Review.

PMID:
24664820
20.

Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.

Lucchini G, Bader P.

Expert Rev Hematol. 2014 Apr;7(2):291-300. doi: 10.1586/17474086.2014.878644. Review.

PMID:
24617334
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk